A detailed history of Birch Financial Group, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Birch Financial Group, LLC holds 14,000 shares of BMEA stock, worth $18,340. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,000
Previous 14,000 -0.0%
Holding current value
$18,340
Previous $25.2 Million 12.22%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Oct 30, 2025

BUY
$1.37 - $2.9 $19,180 - $40,600
14,000 New
14,000 $25.2 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $38.4M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Birch Financial Group, LLC Portfolio

Follow Birch Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Financial Group, LLC with notifications on news.